On the other hand, CD38 is mainly regarded as the biomarker of the Plasma Blast-Plasma cell, particularly highly and uniformly expressed in Multiple Myeloma, a cancer characterized by proliferation of malignant plasma cells in the bone marrow. This evidence concerns the gene CD38 and plasma cell myeloma.